This is a limited company view. Sign up for a Free Trial to see everything.

Asterion is developing novel therapeutic products (ProFuse, Third-generation AFT) with superior pharmacological profiles that will improve the current treatment options for patients with chronic and debilitating diseases

B2B
Biotechnology
Cleantech
Healthcare
Pharmaceuticals
Solar Power
Wind Power

Overview

Location

Sheffield

Founded

Employees

0

Stage

Unknown

Total funding

$678K

Last funding

12 years ago

Acquisitions

0

Growth score

-21

Mindshare score

-21

Scoring

Deals

$678.0K Venture

Fusion IP, Spirit Capital Partners

May 15, 2006

Employee Growth

Use Asterion's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Asterion's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Similar Companies

Alethia BioTherapeutics

Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Series B

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes